145 related articles for article (PubMed ID: 24970749)
1. Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats.
Mousavi Y; Azizi H; Mirnajafi-Zadeh J; Javan M; Semnanian S
Neurosci Lett; 2014 Aug; 578():90-4. PubMed ID: 24970749
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
[TBL] [Abstract][Full Text] [Related]
3. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
[TBL] [Abstract][Full Text] [Related]
4. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons.
Fakhari M; Azizi H; Semnanian S
Neuroscience; 2017 Nov; 363():1-10. PubMed ID: 28888954
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus.
Hooshmandi M; Hosseinmardi N; Janahmadi M; Khakpai F; Rohampour K; Doostmohammadi J
Pharmacol Biochem Behav; 2017 Jul; 158():39-48. PubMed ID: 28583577
[TBL] [Abstract][Full Text] [Related]
6. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
Hooshmand B; Azizi H; Javan M; Semnanian S
Neurosci Lett; 2017 Jan; 636():276-281. PubMed ID: 27816550
[TBL] [Abstract][Full Text] [Related]
7. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S
Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689
[TBL] [Abstract][Full Text] [Related]
8. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats.
Ghaemi-Jandabi M; Azizi H; Ahmadi-Soleimani SM; Semnanian S
Brain Res Bull; 2017 Apr; 130():107-111. PubMed ID: 28093335
[TBL] [Abstract][Full Text] [Related]
9. Blockade of orexin receptor 1 attenuates the development of morphine tolerance and physical dependence in rats.
Erami E; Azhdari-Zarmehri H; Rahmani A; Ghasemi-Dashkhasan E; Semnanian S; Haghparast A
Pharmacol Biochem Behav; 2012 Dec; 103(2):212-9. PubMed ID: 23010422
[TBL] [Abstract][Full Text] [Related]
10. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.
Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
J Physiol Sci; 2019 Mar; 69(2):281-293. PubMed ID: 30406600
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of orexin receptor 1 contributes to the development of morphine dependence via attenuation of cAMP response element-binding protein and phospholipase Cβ
Kourosh-Arami M; Javan M; Semnanian S
J Chem Neuroanat; 2020 Oct; 108():101801. PubMed ID: 32404265
[TBL] [Abstract][Full Text] [Related]
12. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats.
Aghajani N; Pourhamzeh M; Azizi H; Semnanian S
Neurosci Lett; 2021 Jun; 755():135909. PubMed ID: 33892002
[TBL] [Abstract][Full Text] [Related]
13. Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
Kourosh-Arami M; Joghataei MT; Komaki A; Gholami M; Najafi Z; Lavaie M
Int J Neurosci; 2022 Jan; 132(1):67-76. PubMed ID: 32746675
[TBL] [Abstract][Full Text] [Related]
14. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
Sharf R; Sarhan M; Dileone RJ
Biol Psychiatry; 2008 Aug; 64(3):175-83. PubMed ID: 18423425
[TBL] [Abstract][Full Text] [Related]
15. The role of orexin type-1 receptors in the development of morphine tolerance in locus coeruleus neurons: An electrophysiological perspective.
Abdollahi H; Ghaemi-Jandabi M; Azizi H; Semnanian S
Brain Res; 2016 Sep; 1646():91-97. PubMed ID: 27235867
[TBL] [Abstract][Full Text] [Related]
16. Blockade of orexin type 1 receptors inhibits the development of morphine tolerance in lateral paragigantocellularis nucleus: an electrophysiological approach.
Ghaemi-Jandabi M; Azizi H; Semnanian S
Brain Res; 2014 Aug; 1578():14-22. PubMed ID: 25010816
[TBL] [Abstract][Full Text] [Related]
17. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal.
Davoudi M; Vijeepallam K; Azizi H; Mirnajafi-Zadeh J; Semnanian S
J Neural Transm (Vienna); 2019 Nov; 126(11):1425-1435. PubMed ID: 31493096
[TBL] [Abstract][Full Text] [Related]
18. Orexin type 1 receptor antagonism in rat locus coeruleus prevents the analgesic effect of intra-LC met-enkephalin microinjection.
Mohammad Ahmadi Soleimani S; Azizi H; Mirnajafi-Zadeh J; Semnanian S
Pharmacol Biochem Behav; 2015 Sep; 136():102-6. PubMed ID: 26210888
[TBL] [Abstract][Full Text] [Related]
19. Examining the effect of the CaMKII inhibitor administration in the locus coeruleus on the naloxone-precipitated morphine withdrawal signs in rats.
Navidhamidi M; Semnanian S; Javan M; Goudarzvand M; Rohampour K; Azizi H
Behav Brain Res; 2012 Jan; 226(2):440-4. PubMed ID: 22004981
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test.
Azhdari-Zarmehri H; Esmaeili MH; Sofiabadi M; Haghdoost-Yazdi H
Pharmacol Biochem Behav; 2013 Nov; 112():64-70. PubMed ID: 24125787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
